Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001104659-22-024835 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +31.2K | 508.4K | +7% | $0 |
| D | 2022-02-17 | 2022-02-15 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +187.5K | 187.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | A | A | 31,250 | $0.00 | 508,408 | D | — | — | (F1) Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on February 15, 2023, 2024 and 2025. |
| 2 | Derivative | Stock Option (right to buy) | 2022-02-15 | A | A | 187,500 | $0.00 | 187,500 | D | $28.73 · — to 2032-02-14 | 187,500 Common Stock | (F2) The stock option vests in 48 equal monthly installments following the date of grant. |